BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  Enveric Biosciences to Participate in the UBS 3rd Virtual CNS Day

  June 9, 2026

   · 

  3 min read
• Press Releases

  Zetagen Therapeutics Presents Phase 2a Results at ASCO for Investigational ZetaMet™ (Zeta BC 003) in Metastatic Breast Cancer Patients with Lytic Bone Lesions

  June 9, 2026

   · 

  5 min read
• Press Releases

  Watchmaker to Unveil New Technologies Addressing NGS Workflow Bottlenecks and Sequencing Accuracy Challenges at ESHG 2026

  June 9, 2026

   · 

  4 min read
• Press Releases

  Syntis Bio Strengthens Leadership Team with Appointment of Matt Dallas as Chief Financial Officer

  June 9, 2026

   · 

  2 min read
• Press Releases

  Alpha Cognition Reports Positive Top-Line Results from BEACON Real-World Study of ZUNVEYL® in Alzheimer’s Disease

  June 9, 2026

   · 

  12 min read
• 

  HIV

  Merck, Gilead serve ‘sweet and sour’ spread after HIV win, cancer stumble

  While Merck and Gilead Sciences reported back-to-back late-stage victories for their weekly HIV pill, the partners also discontinued a Phase 3 program for their cancer combo after disappointing lung cancer survival data.

  June 9, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Palisade Bio to Present on the Potential of PALI-2108 for Fibrostenotic Crohn’s Disease at New York Academy of Sciences Symposium

  June 9, 2026

   · 

  4 min read
• Press Releases

  International Myeloma Foundation (IMF) and International Myeloma Working Group (IMWG) to Honor 2026 Kyle and Durie Achievement Awardees, Dr. Hermann Einsele and Dr. Noopur Raje

  June 9, 2026

   · 

  8 min read
• Press Releases

  Ernexa Therapeutics Highlights Ovarian Cancer Unmet Need, Hope for Patients and Potential Accessibility Advantages of ERNA-101 in Virtual Investor KOL Connect Segment Featuring Dr. Ira Winer

  June 9, 2026

   · 

  3 min read
• Press Releases

  Imviva Biotech Receives FDA Investigational New Drug Approval for CTA313, a Dual-Targeted CD19/BCMA Allogeneic CAR-T Cell Therapy for Autoimmune Diseases

  June 9, 2026

   · 

  3 min read